Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | Belfast Health & Social Care Trust |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement. |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 6 June 2025 |
| Application Deadline: |
All 3 notices for this procurement, oldest first.
ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 vial
ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each
ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
PROCUREMENT OF ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each
Published contracts in the last 12 months
189
total contracts
£110.4m
total value
£13,803,922
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| — |
| Procurement ID (OCID): | ocds-h6vhtk-051a10 |
| Notice Reference: | 030616-2025 |